Sequence Similarity Clusters for the Entities in PDB 3W12

Entity #1 | Chains: E
Insulin receptor domains L1-CR protein, length: 310 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 7 7 11636
95 % 7 7 11240 Flexibility: Low
Max RMSD: 1.4, Avg RMSD: 0.8
PDBFlex
90 % 7 7 11094
70 % 7 7 10473
50 % 7 7 9439
40 % 7 7 8545
30 % 7 7 7240
Entity #2 | Chains: C
monoclonal antibody fab 83-7 fragment - heavy chain protein, length: 116 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 5 5 16898
95 % 5 5 15684 Flexibility: No
Max RMSD: 0.7, Avg RMSD: 0.5
PDBFlex
90 % 5 5 15355
70 % 65 76 543
50 % 542 609 6
40 % 5442 5756 1
30 % 6754 7175 1
Entity #3 | Chains: D
monoclonal antibody fab 83-7 fragment - light chain protein, length: 114 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 5 5 16672
95 % 5 5 15479 Flexibility: No
Max RMSD: 0.7, Avg RMSD: 0.5
PDBFlex
90 % 5 7 11123
70 % 178 215 66
50 % 265 317 23
40 % 309 361 27
30 % 6755 7175 1
Entity #4 | Chains: A
Insulin A chain protein, length: 21 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 222 289 6
95 % 223 295 8 Flexibility: Low
Max RMSD: 4.4, Avg RMSD: 0.9
PDBFlex
90 % 224 297 9
70 % 228 303 11
50 % 228 303 16
40 % 228 303 29
30 % 228 303 45
Entity #5 | Chains: B
Insulin B chain protein, length: 26 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 216 265 7
95 % 229 302 7
90 % 229 302 8
70 % 229 305 12
50 % 229 305 17
40 % 229 305 31
30 % 229 305 47
Entity #6 | Chains: F
Insulin receptor alpha-CT peptide protein, length: 16 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
3 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
4 5IVN 1 A BC2-nanobody 30538
5 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
6 5E7B 1 A nanobody nano-L06 9838
7 2P45 2 B ANTIBODY CAB-RN05 9838
8 2X1Q 1 A, B GELSOLIN NANOBODY 9844
9 5U64 1 B VHH-28 9838
10 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
11 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
12 4B41 1 A, B ANTIBODY G7 9844
13 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
14 4NZU 1 L 13PL heavy chain Fab 9606
15 4NZU 2 H 13PL light chain Fab 9606
16 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
17 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
18 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
19 5IMM 1 B Nanobody 9835
20 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
21 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
22 5NLU 1 A single domain llama antibody Nb36 9844
23 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
24 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
25 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 1MEX 1 L Fab 29G12 light chain 10090
27 1MEX 2 H Fab 29G12 heavy chain 10090
28 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
29 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
30 5IMK 1 B Nanobody 9835
31 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
32 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
33 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
34 6EH4 2 E Human T Cell Receptor Beta Chain 9606
35 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
36 4BUH 1 A, B CLONE M0418 SCFV 9606
37 4B50 1 A 2H10 LLAMA VHH 9844
38 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
39 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
40 6FR4 1 A TCR 003 alpha chain 9606
41 6FR4 2 B TCR 003 Beta Chain 9606
42 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
43 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
44 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
45 6EH5 2 B Human T Cell Receptor Beta Chain 9606
46 2XT1 2 B CAMELID VHH 9 30538
47 5UD9 1 H Fab heavy chain 9606
48 5UD9 2 L Light chain 9606
49 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
50 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
51 4P48 1 A Antibody scFv 180 9031
52 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
53 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
54 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
55 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
56 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
57 6FR3 1 A 003 TCR Alpha Chain 9606
58 6FR3 2 B 003 TCR Beta Chain 9606
59 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
60 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
61 5J1S 3 C VHH domain BS-2 30538
62 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
63 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
64 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
65 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
66 5L6Q 1 A, B H5AL 9606
67 5J1T 3 C VHH domain BS-2 30538
68 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
69 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
70 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
71 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
72 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
73 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
74 4XCF 1 L 4E10 Fab light chain 9606
75 4XCF 2 H 4E10 Fab heavy chain 9606
76 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
77 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
78 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
79 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
80 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
81 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
82 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
83 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
84 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
85 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
86 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
87 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
88 5X08 1 H Fab 4E10 Heavy chain 9606
89 5X08 2 L Fab 4E10 Light chain 9606
90 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
91 2X1O 1 A, B GELSOLIN NANOBODY 9844
92 4QGY 1 A, B nanobody n25, VH domain 9844
93 5C2B 1 H scFv 3B4 heavy chain 9606
94 5C2B 2 L 3B4 light chain 9606
95 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
96 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
97 4XAW 1 L 4E10 Fab light chain 9606
98 4XAW 2 H 4E10 Fab heavy chain 9606
99 5VNV 1 A Nb.b201 32630
100 4P49 1 A Antibody scFv B8 9031
101 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
102 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
103 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
104 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
105 5DXW 1 A PD-L1 nanobody 10090
106 2NW2 1 A ELS4 TCR alpha chain 9606
107 2NW2 2 B ELS4 TCR beta chain 9606
108 5UCB 1 H Fab Heavy Chain 9606
109 5UCB 2 L Fab Light Chain 9606
110 3T0W 1 A, B immunoglobulin variable lambda domain 9606
111 2VXV 1 H HUMAN IGG ABT-325 9606
112 2VXV 2 L HUMAN IGG ABT-325 9606
113 4N9O 2 B Nanobody Nb484 Nb484 9844
114 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
115 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
116 3T0V 1 A immunoglobulin variable lambda domain 9606
117 4GXV 1 H, I Antibody 1F1, heavy chain 9606
118 4GXV 2 L, M Antibody 1F1, light chain 9606
119 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
120 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
121 2VXT 1 H MURINE IGG 125-2H 10090
122 2VXT 3 L MURINE IGG 125-2H 10090
123 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
124 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
125 1T2J 1 A M12-Variable Heavy domain 9606
126 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
127 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
128 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
129 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
130 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
131 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
132 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
133 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
134 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
135 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
136 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
137 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
138 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
139 5W24 1 L 5C4 Fab Light Chain 10090
140 5W24 2 H 5C4 Fab Heavy Chain 10090
141 4HPY 1 H CH59 Fab heavy chain 9606
142 4HPY 2 L CH59 Fab light chain 9606
143 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
144 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
145 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
146 5VM6 1 A single domain camelid nanobody VHH T10 9844
147 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
148 4JG1 1 L Fab light chain 9606
149 4JG1 2 H Fab heavy chain 9606
150 1SQ2 2 N novel antigen receptor 7801
151 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
152 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
153 4KML 2 B Nanobody 9844
154 5VF2 1 A scFv 2D10 10090
155 5I8C 1 A VRC34.01 Fab heavy chain 9606
156 5I8C 2 B VRC34.01 Fab light chain 9606
157 4O5L 1 L Fab F045-092 light chain 9606
158 4O5L 2 H Fab F045-092 heavy chain 9606
159 5MYX 1 A, C Fab c#24 light chain 10090
160 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
161 4Z9K 2 B VHH2(F5) antibody 30538
162 3IFL 1 L 12A11 FAB antibody light chain 10090
163 3IFL 2 H 12A11 FAB antibody heavy chain 10090
164 5WK2 1 L M116 LIGHT CHAIN 9606
165 5WK2 2 H M116 HEAVY CHAIN FD 9606
166 3PP4 1 H GA101 Fab heavy chain 10090
167 3PP4 2 L GA101 Fab light chain 10090
168 3KDM 1 A, L Immunoglobulin light chain 9606
169 3KDM 2 B, H Immunoglobulin heavy chain 9606
170 5NIV 1 A Light chain of 5D3 Fab 10090
171 5NIV 2 B Heavy chain of 5D3 Fab 10090
172 5N4J 1 L LIGHT CHAIN 9606
173 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
174 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
175 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
176 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
177 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
178 5X4G 1 A 6H8 Fab heavy chain 10090
179 5X4G 2 B 6H8 Fab light chain 10090
180 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
181 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
182 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
183 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
184 4PTU 1 A Antibody pn132p2C05, light chain 9606
185 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
186 4TPR 1 L If kappa light chain 10090
187 4TPR 2 H Fab heavy chain 10090
188 5LMW 1 A Nanobody 9844
189 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
190 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
191 3IFN 1 H 12A11 FAB antibody heavy chain 10090
192 3IFN 2 L 12A11 FAB antibody light chain 10090
193 5U3P 1 H DH511.4 Fab Heavy Chain 9606
194 5U3P 2 L DH511.4 Fab Light Chain 9606
195 6BLA 1 H AMM01 Fab Heavy chain 9606
196 6BLA 2 L AMM01 Fab Light chain 9606
197 5NM0 1 A, B, C, D Nb36 9844
198 4TOY 1 H 35O22 Fab Heavy chain 9606
199 4TOY 2 L 35O22 Fab Light chain 9606
200 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
201 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
202 3NPS 2 B S4 FAB HEAVY CHAIN 9606
203 3NPS 3 C S4 FAB LIGHT CHAIN 9606
204 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
205 5I4F 1 A scFv 2D10 10090
206 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
207 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
208 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
209 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
210 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
211 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
212 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
213 5WN9 1 H scFv 2D10 9606
214 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
215 4XC3 1 L 4E10 Fab light chain 9606
216 4XC3 2 H 4E10 Fab heavy chain 9606
217 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
218 4PPT 1 A Engineered single domain VHH antibody 9844
219 3R0M 1 A, B Llama VHH A12 9844
220 4M5Y 1 H, I Fab 5J8 heavy chain 9606
221 4M5Y 2 L, M Fab 5J8 light chain 9606
222 4TQE 1 L If kappa light chain 10090
223 4TQE 2 H Fab heavy chain 10090
224 3ZKQ 2 D XA4813 9844
225 4I13 2 B Protein ca1697 (nanobody) 9844
226 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
227 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
228 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
229 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
230 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
231 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
232 5C2U 1 B Nanobody Nanobody 9838
233 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
234 5VSI 2 L CH1/Ckappa Fab light chain 9606
235 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
236 1XFP 1 A heavy chain antibody VHH domain 9838
237 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
238 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
239 5JXA 1 H VRC03 Heavy chain 9606
240 5JXA 2 L VRC03 Light chain 9606
241 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
242 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
243 4POY 1 A VHH-metal 9844
244 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
245 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
246 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
247 5NLW 1 A nanobody Nb36 9844
248 3CDC 1 A, B Light Chain Amyloidogenic 9606
249 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
250 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
251 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
252 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
253 3NTC 1 L Fab light chain 10090
254 3NTC 2 H Fab heavy chain 10090
255 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
256 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
257 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
258 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
259 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
260 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
261 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
262 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
263 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
264 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
265 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
266 6BE3 1 H Fab (F598) Heavy Chain 9606
267 6BE3 2 L Fab (F598) Light Chain 9606
268 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
269 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
270 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
271 3G9A 2 B Minimizer 9838
272 4NWU 1 H APE1551 Ab Fab heavy chain 9606
273 4NWU 2 L APE1551 Ab Fab light chain 9606
274 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
275 1KGC 1 D T-cell receptor alpha chain 9606
276 1KGC 2 E T-cell receptor beta chain 9606
277 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
278 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
279 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
280 6FRC 2 B Human T-Cell Receptor beta Chain 9606
281 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
282 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
283 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
284 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
285 5EWI 1 H VRC38.01 Heavy Chain 9606
286 5EWI 2 L VRC38.01 Light Chain 9606
287 5E2W 1 L AT8 LIGHT CHAIN 10090
288 5E2W 2 H AT8 HEAVY CHAIN 10090
289 5MYK 1 A Fab c#17 light chain 10090
290 5MYK 2 B Fab c#17 heavy chain 10090
291 6FUQ 1 A Human F11 T-Cell Receptor 9606
292 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
293 4NZR 1 H PGT135 heavy chain Fab 9606
294 4NZR 2 L PGT135 light chain Fab 9606
295 5MYO 1 A, C Fab c#6 light chain 10090
296 5MYO 2 B, D Fab c#6 heavy chain 10090
297 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
298 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
299 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
300 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
301 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
302 5UEL 1 H 354NC102 Fab Heavy Chain 9606
303 5UEL 2 L 354NC102 Fab Light Chain 9606
304 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
305 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
306 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
307 2P43 2 B ANTIBODY CAB-RN05 9838
308 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
309 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
310 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
311 5E2V 1 L AT8 LIGHT CHAIN 10090
312 5E2V 2 H AT8 HEAVY CHAIN 10090
313 4KRN 1 A Nanobody/VHH domain EgA1 9844
314 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
315 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
316 4GFT 2 B Nanobody 9844
317 4TVS 2 a, b VHH Domain BS-1 30538
318 4W6Y 2 B Nanobody NbFedF9 9844
319 6EZW 1 B VHH antibody BCD090-M2 9844
320 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
321 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
322 5JUE 1 L light chain of UIC2 Fab 10090
323 5JUE 2 H heavy chain of UIC2 Fab 10090
324 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
325 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
326 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
327 1UAC 2 H Ig VH,anti-lysozyme 10090
328 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
329 5JR1 1 H 10E8 heavy chain 9606
330 5JR1 2 L 10E8 mature light chain 9606
331 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
332 5VF6 1 A single chain variable fragment 9031
333 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
334 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
335 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
336 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
337 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
338 6FR9 2 B T-Cell Receptor F11 beta chain 9606
339 5OB5 2 H fAb Heavy chain 9606
340 5OB5 3 L fAb Light chain 9606
341 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
342 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
343 5I66 1 A 8B6 antibody, heavy chain 10090
344 5I66 2 B 8B6 antibody, light chain 10090
345 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
346 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
347 3QQ9 1 C, L 101F LIGHT CHAIN 10090
348 3QQ9 2 D, H 101F HEAVY CHAIN 10090
349 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
350 5TKK 3 L mouse antibody vFP5.01 light chain 10090
351 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
352 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
353 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
354 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
355 5W6C 1 H UCA Fab heavy chain 9606
356 5W6C 2 L UCA Fab light chain 9606
357 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
358 5I1K 1 L FAB LIGHT CHAIN 9606
359 5I1K 2 H FAB HEAVY CHAIN 9606
360 3OZ9 1 L Fab NC-1 kappa light chain 10090
361 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
362 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
363 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
364 5V7U 1 L CBTAU-22.1 Fab light chain 9606
365 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
366 5UEA 1 A, H Fab Heavy Chain 9606
367 5UEA 3 B, L Fab Light Chain 9606
368 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
369 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
370 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
371 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
372 3G5Y 1 A 175 light chain 10090
373 3G5Y 2 B 175 heavy chain 10090
374 5O02 2 C Nanobody (VHH) Nano-4 30538
375 5NMV 1 L Fab light chain 10088
376 5NMV 2 H Fab heavy chain 10088
377 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
378 4N8C 2 L, M Light chain of monoclonal antibody 10090
379 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
380 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
381 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
382 4HGW 1 A Antibody Fab fragment, light chain 10090
383 4HGW 2 B Antibody Fab fragment, heavy chain 10090
384 1NLB 1 L antibody 19D9D6 light chain 10090
385 1NLB 2 H antibody 19D9D6 heavy chain 10090
386 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
387 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
388 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
389 3VFG 1 L 3F8 Light Chain 10090
390 3VFG 2 H 3F8 Heavy Chain 10090
391 4X7F 2 C, D Nano-25 Nanobody 30538
392 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
393 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
394 3QRG 1 L Fab light chain 9606
395 3QRG 2 H Fab heavy chain Fd fragment 9606
396 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
397 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
398 5M6A 1 A, B, C, D Bence-Jones light chain 9606
399 4LLY 2 B, D light chain Clambda 9606
400 4LGR 2 B Camelid nanobody (VHH3) 30538
401 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
402 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
403 5EZI 1 H Fab c12 heavy chain 9606
404 5EZI 2 L Fab c12 Light chain 9606
405 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
406 4K23 1 H anti-uPAR antibody, heavy chain 10090
407 4K23 2 L anti-uPAR antibody, light chain 10090
408 5J57 2 B VHH single chain antibody V5E1 30538
409 3NCJ 1 L Fab15 Mut8 light chain 9606
410 3NCJ 2 H Fab15 Mut8 heavy chain 9606
411 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
412 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
413 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
414 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
415 5W05 1 L M59 FAB LIGHT CHAIN 10090
416 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
417 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
418 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
419 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
420 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
421 5OMM 2 C Nanobody (VHH) Nano-14 30538
422 5E03 1 A mouse CTLA-4 nanobody 10090
423 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
424 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
425 4M61 1 A, C Fab A52 light chain 10090
426 4M61 2 B, D Fab A52 heavy chain 10090
427 5LZ0 1 A, B PorM nanobody 9844
428 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
429 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
430 1UM5 1 L Antibody 21H3 L chain 10090
431 1UM5 2 H Antibody 21H3 H chain 10090
432 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
433 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
434 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
435 4NWT 1 L APE1531 Ab Fab light chain 9606
436 4NWT 2 H APE1531 Ab Fab heavy chain 9606
437 3WHX 1 A mAb Fab H fragment 10090
438 3WHX 2 B mAb Fab L fragment 10090
439 3NA9 1 L Fab15 light chain 9606
440 3NA9 2 H Fab15 heavy chain 9606
441 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
442 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
443 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
444 6FUO 2 B Human F11 T-Cell Receptor 9606
445 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
446 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
447 4LRI 1 A, B MSL-109 Light Chain 9606
448 4LRI 2 C, P MSL-109 Heavy Chain 9606
449 2XXC 1 B CAMELID VHH 9 30538
450 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
451 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
452 4JN2 1 A, L anti dabigatran Fab 10090
453 4JN2 2 B, H anti dabigatran Fab 10090
454 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
455 4XBE 2 H 4E10 Fab heavy chain 9606
456 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
457 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
458 6BE2 1 H Fab (F598) Heavy Chain 9606
459 6BE2 2 L Fab (F598) Light Chain 9606
460 3QYC 1 A, B VH domain of IgG molecule 9606
461 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
462 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
463 4JFZ 1 L Fab light chain 9606
464 4JFZ 2 H Fab heavy chain 9606
465 5VAK 2 B Nb914 Nanobody 9844
466 3WIF 1 A mAb Fab H fragment 10090
467 3WIF 2 B mAb Fab L fragment 10090
468 5U6A 1 A Light Chain 9606
469 5U6A 2 B Heavy Chain 9606
470 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
471 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
472 3MBX 1 L X836 LIGHT CHAIN 10090
473 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
474 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
475 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
476 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
477 2XXM 2 B CAMELID VHH 9 30538
478 6APC 1 H Epididymis luminal protein 214 9606
479 6APC 2 L IGL@ protein 9606
480 5IR3 1 A Ig lambda chain V-VI region AR 9606
481 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
482 4HHA 1 A Fab KE5 Fab fragment KE5 9606
483 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
484 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
485 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
486 4RGO 2 H 14G8 heavy chain Fab 10090
487 4RGO 3 L 14G8 light chain Fab 10090
488 5GRY 1 A, G diabody 9606
489 5UEK 2 H Fab 12E Heavy Chain 9606
490 5UEK 3 L Fab 12E Light Chain 9606
491 3NAA 1 L Fab15 Mut5 light chain 9606
492 3NAA 2 H Fab15 Mut5 heavy chain 9606
493 1Q0X 1 L Fab 9B1, light chain 10090
494 1Q0X 2 H Fab 9B1, heavy chain 10090
495 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
496 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
497 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
498 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
499 5JDS 1 B Nanobody 9835
500 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
501 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
502 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
503 5IK3 2 B, D 1E03 Fab fragment light chain 9606
504 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
505 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
506 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
507 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
508 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
509 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
510 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
511 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
512 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
513 4WUK 1 H CH65 heavy chain 9606
514 4WUK 2 L CH65 light chain 9606
515 5L8L 2 B New antigen receptor variable domain 168098
516 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
517 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
518 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
519 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
520 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
521 5JOP 1 D, L Fab 14.22 light chain 10090
522 5JOP 2 E, H Fab14.22 heavy chain 10090
523 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
524 4HPO 1 H CH58 Fab heavy chain 9606
525 4HPO 2 L CH58 Fab light chain 9606
526 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
527 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
528 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
529 5UKN 2 L DH522UCA Fab fragment light chain 9544
530 4AIZ 1 A, C, D V2-17 PROTEIN 9606
531 4AIZ 2 B V2-17 PROTEIN 9606
532 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
533 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
534 5L21 2 B VHH-C2 30538
535 5IT2 1 H heavy chain 9606
536 5IT2 2 L light chain 9606
537 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
538 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
539 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
540 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
541 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
542 2W59 1 A, B IGY FCU3-4 9031
543 5FWO 1 A NANOBODY 9844
544 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
545 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
546 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
547 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
548 4L1H 1 A Ig kappa chain V-I region Rei 9606
549 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
550 5MO3 3 L Fab of monoclonal antibody, light chain 10090
551 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
552 5GZ0 1 A, C FM329 light chain 1383439
553 5GZ0 2 B, D FM329 heavy chain 1383439
554 3B9V 1 A, B, C, D heavy chain variable domain 9606
555 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
556 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
557 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
558 6BQB 1 L MGG4 Fab light chain 9606
559 6BQB 2 H MGG4 Fab heavy chain 9606
560 4PUB 1 H DX-2930 HEAVY CHAIN 9606
561 4PUB 2 L DX-2930 LIGHT CHAIN 9606
562 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
563 6B14 2 L Light chain of Fab BL3-6S97N 10090
564 5N88 1 A, H VH59 antibody 9606
565 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
566 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
567 5TEZ 4 I TCR F50 alpha chain 9606
568 5TEZ 5 J TCR F50 beta chain 9606
569 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
570 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
571 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
572 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
573 5GS3 1 A, H diabody protein 9606
574 3BD3 1 A, B catalytic antibody 10090
575 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
576 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
577 2OTU 1 A, C, E, G Fv light chain variable domain 10090
578 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
579 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
580 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
581 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
582 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
583 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
584 5VKD 2 H Fab Heavy Chain 9606
585 5VKD 3 L Fab light chain 9606
586 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
587 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
588 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
589 5XHG 1 A, C polypeptide(L) 562
590 5XHG 2 B, D polypeptide(H) 562
591 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
592 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
593 5L8J 2 B New antigen receptor variable domain 168098
594 3UYR 1 H antibody Fab heavy chain 10090
595 3UYR 2 L antibody Fab light chain 10090
596 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
597 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
598 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
599 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
600 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
601 3OAZ 2 K, L Fab 2G12, light chain 9606
602 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
603 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
604 1T6V 2 N, O novel antigen receptor 7801
605 1ZAN 1 L Fab AD11 Light Chain 10116
606 1ZAN 2 H Fab AD11 Heavy Chain 10116
607 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
608 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
609 4N0Y 1 H IGH526 Heavy Chain 9606
610 4N0Y 2 L IGH526 Light Chain 9606
611 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
612 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
613 5MTH 1 A, H antibody Fab heavy chain 10090
614 5MTH 2 B, L antibody Fab light chain 10090
615 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
616 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
617 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
618 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
619 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
620 1RZF 1 L Fab E51 light chain 9606
621 1RZF 2 H Fab E51 heavy chain 9606
622 4N1C 1 A, B immunoglobulin variable light chain domain 9606
623 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
624 4KTE 2 L GE148 Light Chain Fab 9544
625 5I8O 1 H HMM5 antibody heavy chain 9606
626 5I8O 2 L HMM5 antibody light chain 9606
627 4OUO 1 A anti Bla g 1 scFv 9031
628 4JG0 1 L Fab light chain 9606
629 4JG0 2 H Fab heavy chain 9606
630 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
631 4YGV 2 B, L aDabi-Fab2a light chain 9606
632 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
633 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
634 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
635 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
636 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
637 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
638 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
639 3EO0 1 A, C GC-1008 Fab Light Chain 10090
640 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
641 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
642 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
643 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
644 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
645 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
646 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
647 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
648 6FUR 2 B, D Human F11 T-Cell Receptor 9606
649 4POU 2 B VHH Antibody 9844
650 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
651 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
652 4FQI 3 H antibody CR9114 heavy chain Fab 9606
653 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
654 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
655 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
656 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
657 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
658 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
659 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
660 4JHA 2 L D25 light chain 9606
661 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
662 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
663 4PTT 1 A Antibody pn132p2C05, light chain 9606
664 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
665 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
666 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
667 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
668 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
669 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
670 2P42 2 B, D ANTIBODY CAB-RN05 9838
671 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
672 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
673 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
674 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
675 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
676 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
677 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
678 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
679 4DGV 1 H HCV1 Heavy Chain Fab 9606
680 4DGV 2 L HCV1 Light Chain 9606
681 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
682 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
683 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
684 5TH2 1 A, C cetuximab Fab, light chain 10090
685 5TH2 2 B, D cetuximab Fab, heavy chain 10090
686 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
687 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
688 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
689 5I8K 1 L HHH1 Fab Light chain 9606
690 5I8K 2 H HHH1 Fab Heavy chain 9606
691 4QLR 1 A, B Llama nanobody n02 VH domain 9844
692 5J56 2 B VHH single chain antibody V1C7 30538
693 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
694 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
695 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
696 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
697 1YNL 1 L Ig gamma light chain 10090
698 1YNL 2 H Ig gamma heavy chain 10090
699 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
700 5EPM 2 B, F Antibody Fab fragment light chain 10090
701 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
702 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
703 5VH5 1 A Infliximab Fc 10090
704 3UMT 1 A scFv heavy chain and light chain 10090
705 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
706 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
707 4NUJ 1 A PGT152 light chain 9606
708 4NUJ 2 B PGT152 heavy chain 9606
709 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
710 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
711 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
712 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
713 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
714 3U2S 2 B, L PG9 light chain 9606
715 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
716 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
717 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
718 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
719 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
720 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
721 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
722 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
723 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
724 4NUG 1 L PGT151 light chain 9606
725 4NUG 2 H PGT151 heavy chain 9606
726 3IU4 1 H chP3 Fab heavy chain 10090
727 3IU4 2 L chP3 Fab light chain 10090
728 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
729 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
730 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
731 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
732 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
733 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
734 1P7K 1 A, L antibody light chain FAB 10090
735 1P7K 2 B, H antibody heavy chain FAB 10090
736 4NBX 2 B A20.1 VHH 9844
737 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
738 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
739 3RVV 2 C 4C1 - light chain 10090
740 3RVV 3 D 4C1 - heavy chain 10090
741 4HEP 2 G vHH17 domain 9844
742 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
743 3P0Y 2 H Fab DL11 heavy chain 9606
744 3P0Y 3 L Fab DL11 light chain 9606
745 4NPY 1 A, L germline PGT121 light chain Fab 9606
746 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
747 6ANA 2 H LL2 Fab Heavy Chain 10090
748 6ANA 3 L LL2 Fab Light Chain 10090
749 5IBU 1 B, L 6652 Light Chain 9606
750 5IBU 2 G, H 6652 Heavy Chain 9606
751 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
752 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
753 5VPL 2 C 4C1 - LIGHT CHAIN 10090
754 5VPL 3 D 4C1 - HEAVY CHAIN 10090
755 6AOD 1 A FXIa Antibody FAB Light Chain 9606
756 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
757 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
758 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
759 2YPV 2 H FAB 12C1 10090
760 2YPV 3 L FAB 12C1 10090
761 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
762 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
763 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
764 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
765 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
766 4JY5 1 L PGT122 light chain Fab 9606
767 4JY5 2 H PGT122 heavy chain Fab 9606
768 6ELE 1 A, H fAB heavy chain 9606
769 6ELE 2 B, L fAB light chain 9606
770 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
771 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
772 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
773 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
774 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
775 6B5R 1 H CIS42 Fab Heavy chain 9606
776 6B5R 2 L CIS42 Fab Light chain 9606
777 5IML 2 B Nanobody 9835
778 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606 1.1.1 | Details
779 3NAC 1 L Fab15 Mut7 light chain 9606
780 3NAC 2 H Fab15 Mut7 heavy chain 9606
781 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
782 3A6C 2 H IG VH, anti-lysozyme 10090
783 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
784 2DQD 2 H Ig VH,anti-lysozyme 10090
785 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
786 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
787 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
788 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
789 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
790 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
791 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
792 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
793 1Q72 1 L Fab M82G2, Light chain 10090
794 1Q72 2 H Fab M82G2, Heavy chain 10090
795 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
796 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
797 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
798 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
799 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
800 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
801 4YHO 1 H aDabi-Fab3 heavy chain 9606
802 4YHO 2 L aDabi-Fab3 light chain 9606
803 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
804 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
805 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
806 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
807 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
808 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
809 4DGY 1 H HCV1 Heavy Chain Fab 9606
810 4DGY 2 L HCV1 Light Chain 9606
811 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
812 3A67 2 H IG VH, anti-lysozyme 10090
813 2APB 1 A T-cell receptor beta chain V 10116
814 2APX 1 A T cell receptor beta chain V 10116
815 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
816 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
817 6EH6 2 B Human T Cell Receptor BetaChain 9606
818 5EN2 1 A GD01 heavy chain 10090
819 5EN2 2 B GD01 light chain 10090
820 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
821 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
822 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
823 1J1X 2 H Ig VH,anti-lysozyme 10090
824 5L8K 2 B New antigen receptor variable domain 168098
825 5M2J 2 D Anti-(ED-B) scFV 9606
826 3MXW 2 L 5E1 light chain 9606
827 3MXW 3 H 5E1 heavy chain 9606
828 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
829 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
830 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
831 2DQC 2 H Ig VH,anti-lysozyme 10090
832 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
833 1J1O 2 H Ig VH,anti-lysozyme 10090
834 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
835 3EO9 1 L Efalizumab Fab fragment, light chain 9606
836 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
837 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
838 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
839 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
840 4M62 2 H, I GEP2 FV heavy chain 9606
841 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
842 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
843 5IVO 1 A BC2-nanobody 30538
844 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
845 1J1P 2 H Ig VH,anti-lysozyme 10090
846 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
847 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
848 4NBZ 2 B, D A26.8 VHH 9844
849 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
850 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
851 5WUV 1 L light chain 9606
852 5WUV 2 H heavy chain 9606
853 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
854 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
855 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
856 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
857 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
858 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
859 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
860 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
861 5AYU 2 H Ig VH,anti-lysozyme 10090
862 4JM4 1 H PGT 135 Heavy Chain Fab 9606
863 4JM4 2 L PGT 135 Light Chain Fab 9606
864 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
865 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
866 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
867 3A6B 2 H IG VH, anti-lysozyme 10090
868 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
869 2DQJ 2 H Ig VH,anti-lysozyme 10090
870 5F21 2 B nanobody MU375 9844
871 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
872 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
873 6B0G 1 C 1245 Antibody, Light Chain 9606
874 6B0G 2 D 1245 Antibody, Heavy Chain 9606
875 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
876 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
877 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
878 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
879 4WNQ 1 A, C TCR Variable Delta 1 chain and TCR constant Alpha chain 9606
880 4WNQ 2 B, D TCR Variable Beta 2 (TRBV20) chain and TCR constant Beta chain 9606
881 2Q86 1 A, C Valpha14 TCR extracellular domain 10090
882 2Q86 2 B, D Vbeta8.2 extracellular domain 10090
883 2P44 2 B ANTIBODY CAB-RN05 9838
884 6BE4 1 H Fab (F598) Heavy Chain 9606
885 6BE4 2 L Fab(F598) Light Chain 9606
886 6FRB 1 A Human T-Cell Receptor F11 alpha chain 9606
887 6FRB 2 B Human T-Cell Receptor F11 beta Chain 9606
888 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
889 5TPP 1 L DH270.5 Fab heavy chain 9606
890 5TPP 2 H DH270.5 Fab light chain 9606
891 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
892 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
893 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
894 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
895 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
896 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
897 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
898 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
899 5TP3 1 A, B F-VHH-4 9844
900 5D7K 1 D MAV36 TCR Alpha Chain 9606
901 5D7K 2 E MAV36 TCR Beta Chain 9606
902 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
903 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
904 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
905 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
906 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
907 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
908 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
909 3B5G 1 A, B AMYLOID LAMBDA 6 LIGHT CHAIN VARIABLE REGION PIP residues 1-111 9606
910 5TL5 1 L M2177 LIGHT CHAIN 10090
911 5TL5 2 H M2177 HEAVY CHAIN 10090
912 2JJW 1 A SIGNAL REGULATORY PROTEIN GAMMA ISOFORM 4 N-TERMINAL ECTODOMAIN, RESIDUES 29-147 9606